Industry Insights

  1. Reducing Human Variability in Bioanalysis 3/9/2026

    Automation removes manual variability, creating consistent, repeatable processes that improve precision, strengthen compliance, and produce more reliable data for critical decisions.

  2. Why Your Bioanalysis Bottleneck Is Costing You More Than You Think 3/9/2026

    This piece explains why turnaround time is a strategic variable, where speed is truly achievable, and how automation reshapes the path from sample submission to decision‑ready data.

  3. ICH E6(R3) Is Here: What Your Centralized Monitoring Strategy Needs 3/9/2026

    ICH E6(R3) turns best practices into regulatory mandates. Learn how to maintain sponsor accountability and implement proportionate centralized monitoring through a unified, auditable data layer.

  4. CNS Trials Are Difficult — Do They Have To Be? 3/9/2026

    Clinical trials for central nervous system therapies face significant obstacles to approval, including subjective endpoints and complex patient selection. Consider a strategic approach for success.

  5. Why "Good Enough" Data Is Good Enough For Agentic AI 3/9/2026

    Overcome 'data paralysis' and learn why you don’t need perfect data to start leveraging AI and its benefits, and why starting today is much better than waiting for 'perfect.'

  6. eCOA Standards And KPIs To Include In Your Next RFI 3/9/2026

    Check out this practical roadmap on vendor selection and learn specific performance metrics and quality benchmarks you should ask your next eCOA partner.

  7. Paper COAs in 2026: It's Not Cheaper, It's Riskier 3/9/2026

    Learn why sticking with paper records is a faulty strategy and discover how hidden costs, transcription errors, and regulatory red flags make digital COAs the only safe choice for modern trials.

  8. Why RTSM Software Doesn't Belong Inside An All-In-One Suite 3/9/2026

    Don’t let administrative convenience compromise study integrity. Discover why purpose-built RTSM is essential for managing the technical complexities and specialized demands of modern trials.

  9. Unblinding Risks In RTSM: What's Still Going Wrong, And How Korio Fixes It 3/9/2026

    Protecting study integrity requires more than just luck. Learn how systemic gaps lead to unintentional unblinding and how a proactive, engine-based approach can safeguard your clinical data.

  10. Start-Up Speed vs. Total Trial Success: Balancing RTSM Priorities 3/9/2026

    Don't let a fast startup compromise years of clinical success. Learn how to balance initial build speed with the long-term flexibility needed to handle protocol amendments and complex integrations.